BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghorab MM, Soliman AM, Bua S, Supuran CT. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors. Bioorg Chem 2021;107:104618. [PMID: 33485104 DOI: 10.1016/j.bioorg.2020.104618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zahran SS, Ragab FA, El-gazzar MG, Soliman AM, Mahmoud WR, Ghorab MM. Antiproliferative, antiangiogenic and apoptotic effect of new hybrids of quinazoline-4(3H)-ones and sulfachloropyridazine. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114912] [Reference Citation Analysis]
2 Abdel-Mohsen HT, Omar MA, Petreni A, Supuran CT. Novel 2-substituted thioquinazoline-benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity. Arch Pharm (Weinheim) 2022;:e2200180. [PMID: 36056903 DOI: 10.1002/ardp.202200180] [Reference Citation Analysis]
3 Nerella SG, Singh P, Arifuddin M, Supuran CT. Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opin Ther Pat 2022. [PMID: 35616541 DOI: 10.1080/13543776.2022.2083502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Soliman AM, Khalil A, Ramadan E, Ghorab MM. Induction of apoptosis, cytotoxicity and radiosensitization by novel 3,4-dihydroquinazolinone derivatives. Bioorg Med Chem Lett 2021;49:128308. [PMID: 34363937 DOI: 10.1016/j.bmcl.2021.128308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]